Conmed

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Conmed and other ETFs, options, and stocks.

About CNMD

CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. Its products include AirSeal and insufflation, allograft cartilage and tissue, arthroplasty, biliary and endoscopic ultrasound, biomedical sensors and electrodes, biopsy and polypectomy, dilators and accessories, electrosurgical units, fixation devices, hemostasis, implants and suture anchors, infection prevention, patient positioning, and related products. 

CEO
Patrick Joseph Beyer
CEOPatrick Joseph Beyer
Employees
3,900
Employees3,900
Headquarters
Largo, Florida
HeadquartersLargo, Florida
Founded
1970
Founded1970
Employees
3,900
Employees3,900

CNMD Key Statistics

Market cap
1.33B
Market cap1.33B
Price-Earnings ratio
20.84
Price-Earnings ratio20.84
Dividend yield
1.86%
Dividend yield1.86%
Average volume
597.43K
Average volume597.43K
High today
$43.51
High today$43.51
Low today
$41.81
Low today$41.81
Open price
$42.70
Open price$42.70
Volume
733.19K
Volume733.19K
52 Week high
$74.70
52 Week high$74.70
52 Week low
$38.32
52 Week low$38.32

Stock Snapshot

With a market cap of 1.33B, Conmed(CNMD) trades at $42.91. The stock has a price-to-earnings ratio of 20.84 and currently yields dividends of 1.9%.

As of 2026-01-11, Conmed(CNMD) stock has fluctuated between $41.81 and $43.51. The current price stands at $42.91, placing the stock +2.6% above today's low and -1.4% off the high.

The Conmed(CNMD)'s current trading volume is 733.19K, compared to an average daily volume of 597.43K.

In the last year, Conmed(CNMD) shares hit a 52-week high of $74.70 and a 52-week low of $38.32.

In the last year, Conmed(CNMD) shares hit a 52-week high of $74.70 and a 52-week low of $38.32.

CNMD News

TipRanks 3d
Conmed CFO Todd Garner to step down, effective March 15

Conmed (CNMD) announced the departure of Todd Garner from his role as CFO, effective March 15. To ensure a smooth and orderly transition, Garner will remain wit...

Analyst ratings

83%

of 6 ratings
Buy
16.7%
Hold
83.3%
Sell
0%

People also own

Based on the portfolios of people who own CNMD. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.